← FDA Drug Approvals (Drugs@FDA)

IOBENGUANE I-123

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BWXT MEDCL · Approved 2024-12-09

Drug application

FDA Application #

ANDA213637

Application type

Abbreviated New Drug Application (Generic)

Brand name

IOBENGUANE I-123

Generic name

Iobenguane Sulfate I-123

Active ingredients

IOBENGUANE SULFATE I-123

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

BWXT MEDCL

First approval

2024-12-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown